Andrea Tan
Stock Analyst at Goldman Sachs
(0.94)
# 3,551
Out of 4,829 analysts
45
Total ratings
35.29%
Success rate
-12.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $1.92 | +317.75% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $45.16 | +12.93% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $6.74 | +300.59% | 6 | Mar 25, 2025 | |
| INSM Insmed | Maintains: Buy | $74 → $102 | $68.12 | +49.75% | 9 | Jul 10, 2024 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $3.45 | +73.91% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $14.10 | +119.86% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $0.40 | +399.88% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $4.17 | -52.04% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $139.06 | +15.06% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $2.09 | +1,051.08% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.10 | +263.64% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $301.68 | +24.30% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $13 | $4.34 | +199.54% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $0.17 | +2,292.34% | 2 | May 24, 2022 |
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $1.92
Upside: +317.75%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $45.16
Upside: +12.93%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $6.74
Upside: +300.59%
Insmed
Jul 10, 2024
Maintains: Buy
Price Target: $74 → $102
Current: $68.12
Upside: +49.75%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $3.45
Upside: +73.91%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $14.10
Upside: +119.86%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $0.40
Upside: +399.88%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $4.17
Upside: -52.04%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $139.06
Upside: +15.06%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $2.09
Upside: +1,051.08%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.10
Upside: +263.64%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $301.68
Upside: +24.30%
Dec 15, 2022
Initiates: Sell
Price Target: $13
Current: $4.34
Upside: +199.54%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $0.17
Upside: +2,292.34%